NSNicolai Fink Simonsen

Nicolai Fink Simonsen

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Nicolai Fink Simonsen has a total of 27 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Health trajectories of early career hospital nurses and midwives compared to other graduates in Denmark

    by Louise Schubert Paaske, Nicolai Simonsen Damslund, Anne Helene Gaarde, Ann Dyreborg Larsen, Kim Rose Olsen

  • Open Access

    Beyond the gate: Referral style and utilisation of primary sector specialist care

    by Sasja Maria Pedersen, Kim Rose Olsen, Nicolai Damslund, Thomas Allen, Trine Kjær

  • Open Access

    Comparative Long-Term Mortality and Societal and Individual Socioeconomic Consequences of Autoimmune and Herpes Encephalitis: A Nationwide Cohort Study

    by Thomas Agerbo Gaist, Line Planck Kongstad, Lærke Storgaard Duerlund, Nicolai Fink Simonsen, Mette Scheller Nissen, Jacob Hjelmborg, Carsten Finke, Sarosh Irani, Jacob Bodilsen, Morten Blaabjerg

    Background: The WHO prioritizes encephalitis as an urgent and global public health imperative with serious consequences for survivors. Socioeconomic outcomes remain poorly studied yet are imperative to addressing the WHO recommendations. No population-based studies have systematically assessed and compared individual consequences and societal outcomes of infectious and autoimmune encephalitis.Methods: Patients with serologically confirmed autoimmune encephalitis (AE) and patients with microbiologically confirmed herpes simplex type 1 encephalitis (HSE) were matched with general population controls on sociodemographic characteristics. Differences in societal costs, personal socioeconomic outcomes and mortality were analyzed using regression-based statistical models.Findings: A total of 117 AE patients were matched with 70,994 controls, and 112 HSE patients with 47,659 controls. Both groups incurred substantially higher societal costs compared to controls, averaging €134,000 per patient [95% CI 109,000 to 160,000] for AE and €113,000 [90,000 to 135,000] for HSE over a six-year period.Five years after diagnosis, individual socioeconomic outcomes remained markedly worse compared to background population controls. Absolute risk difference of labor market participation was reduced by 31% [16 to 45] and 28% [10 to 46], for AE and HSE, respectively. The probability of receiving disability pension increased for both AE (11% [2 to 20]) and HSE (28% [9 to 46]) and institutionalization was 13% [3 to 23] higher in HSE patients than in controls. Annual transfer income increased considerably, particularly among HSE patients. The 5-year cumulative mortality risk difference was 22% [14 to 30] for AE and 34% [24 to 44] for HSE.Interpretation: Encephalitis is associated with substantial long-term mortality and individual and societal burdens regardless of etiology. These observations advance WHO advice by providing population-based quantification of the consequences of this condition which is likely to become an increasing global concern.

  • Open Access

    Protecting healthcare workers? Effects of a multilevel intervention targeting emotional demands

    by Louise Schubert Paaske, Nicolai Simonsen Damslund, Ida Elisabeth Huitfeldt Madsen, Sofie Østergaard Jaspers, Line Planck Kongstad

    Healthcare workers are frequently exposed to high emotional demands through encounters with patient suffering, death, worries, and aggressive reactions. Su

  • Open Access

    Do Physicians Respond to Additional Capitation Payments in Mixed Remuneration Schemes?

    by Line Planck Kongstad, Nicolai Damslund, Jens Søndergaard, Geir Godager, Kim Rose Olsen

    Mixed remuneration schemes with capitation and fee‐for‐service (FFS) payments hold financial incentives to add patients to the list and provide services to listed patients. However, as patients with complex needs tend to require longer consultations there is a risk of inequality in access if fees are not adjusted to patient characteristics. In this paper, we assess a natural experiment introducing additional capitation for GPs with a high share of complex patients (moderate scheme) and for GPs in certain geographical areas (intensive scheme). GPs are eligible if the complexity of their listed patients exceeds a threshold, but as the scheme is subject to a national budget constraint, some eligible general practitioners (GPs) are left without additional payment. For the most favored GPs, the reform distributed additional capitation at 8% of the total baseline income. We study the effects on the number of patients per GP and the number of services per patient, applying difference‐in‐difference (DiD) models. For both schemes (moderate and intensive), we find tendencies of reductions in the number of patients served and the level of service provision per patient. This also holds for complex patients indicating that the reform did not improve equity in access. The effect on income showed a 2.5% increase in the first follow‐up year but the effect became insignificant in the second year after the reform. We interpret this result as a sign that GPs trade income increases with leisure as suggested by the target income hypothesis.


  • Open Access

    Optimising test intervals for individuals with type 2 diabetes: A machine learning approach

    by Sasja Maria Pedersen, Nicolai Damslund, Trine Kjær, Kim Rose Olsen

    Background: Chronic disease monitoring programs often adopt a one-size-fits-all approach that does not consider variation in need, potentially leading to excessive or insufficient support for patients at different risk levels. Machine learning (ML) developments offer new opportunities for personalised medicine in clinical practice. Objective: To demonstrate the potential of ML to guide resource allocation and tailored disease management, this study aims to predict the optimal testing interval for monitoring blood glucose (HbA1c) for patients with Type 2 Diabetes (T2D). We examine fairness across income and education levels and evaluate the risk of false-positives and false-negatives. Data: Danish administrative registers are linked with national clinical databases. Our population consists of all T2D patients from 2015-2018, a sample of more than 57,000. Data contains patient-level clinical measures, healthcare utilisation, medicine, and socio-demographics. Methods: We classify HbA1c test intervals into four categories (3, 6, 9, and 12 months) using three classification algorithms: logistic regression, random forest, and extreme gradient boosting (XGBoost). Feature importance is assessed with SHAP model explanations on the best-performing model, which was XGBoost. A training set comprising 80% of the data is used to predict optimal test intervals, with 20% reserved for testing. Cross-validation is employed to enhance the model’s reliability and reduce overfitting. Model performance is evaluated using ROC-AUC, and optimal intervals are determined based on a “time-to-next-positive-test” concept, with different durations associated with specific intervals. Results: The model exhibits varying predictive accuracy, with AUC scores ranging from 0.53 to 0.89 across different test intervals. We find significant potential to free resources by prolonging the test interval for well-controlled patients. The fairness metric suggests models perform well in terms of equality. There is a sizeable risk of false negatives (predicting longer intervals than optimal), which requires attention. Conclusions: We demonstrate the potential to use ML in personalised diabetes management by assisting physicians in categorising patients by testing frequencies. Clinical validation on diverse patient populations is needed to assess the model’s performance in real-world settings.


  • Pure altruism and misjudgement: A bad combination?

    by Nicolai Fink Simonsen, Trine Kjær, Dorte Gyrd-Hansen


  • What explains differences in waiting times for health care across socioeconomic status?

    by Nicolai Fink Simonsen, Anne Sophie Oxholm, Søren Rud Kristensen, Luigi Siciliani

    In publicly funded health systems, waiting times act as a rationing mechanism that should be based on need rather than socioeconomic status. However, several studies suggest that individuals with higher socioeconomic status wait less. Using individual‐level data from administrative registers, we estimate and explain socioeconomic inequalities in access to publicly funded care for seven planned hospital procedures in Denmark. For each procedure, we first estimate the association between patients' waiting time for health care and their socioeconomic status as measured by income and education, controlling for patient severity. Then, we investigate how much of the association remains after controlling for (i) other individual characteristics (patients' family status, labor market status, and country of origin) that may be correlated with income and education, (ii) possible selection due to patients' use of a waiting time guarantee, and (iii) hospital factors which allow us to disentangle whether inequalities in waiting times arise across hospitals or within the hospital. Only for a few procedures, we find inequalities in waiting times related to income and education. These inequalities can be explained mostly by geographical and institutional factors across hospitals. But we also find inequalities for some procedures in relation to non‐Western immigrants within hospitals.